Speech and language therapy in primary progressive aphasia: a critical review of current practice.
Primary progressive aphasia
aphasia
clinical care
communication
neurodegeneration
speech therapy
speech-language therapy
Journal
Expert review of neurotherapeutics
ISSN: 1744-8360
Titre abrégé: Expert Rev Neurother
Pays: England
ID NLM: 101129944
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
pubmed:
2
3
2021
medline:
29
1
2022
entrez:
1
3
2021
Statut:
ppublish
Résumé
Primary progressive aphasia (PPA) is a complex language-led dementia syndrome whereby disproportionate deterioration of speech and language occurs subsequent to neurodegenerative disease in the early to mid-stages of the condition. As no effective pharmacotherapies are currently available, speech and language therapies are the optimum treatment to maximize communication for as long as possible. The authors present an overview of current speech-language therapy practices in PPA, highlighting recent research on effective treatments. The challenges in this complex field of practice are described. We highlight the challenge of improving access to speech-language therapy by advocating for increased referral rates. The authors also suggest effective incorporation of innovative technologies in treatment and an enhanced evidence base for the utility of lexical retrieval treatment in improving everyday communication as challenges for the future. Finally, increased provision of PPA-specific education and support for individuals and their families is required.
Identifiants
pubmed: 33641570
doi: 10.1080/14737175.2021.1897253
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM